← Every company
Regeneron Pharmaceuticals Inc SEC Filings
What Regeneron Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
REGN overview →Filings on file
142
since Nov 4, 2016
Warning signs
0
none filed
Last results
Oct 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Regeneron Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on REGN
Company overviewEverything on REGN in one place, with the price.Insider tradingWhat REGN's own officers and directors buy and sell.Executive payWhat REGN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in REGN.Funds holding itWhich funds and ETFs hold REGN, and how big a bet.LobbyingWhat REGN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on REGN's account, and who they worked for.Federal contractsWhat federal agencies pay REGN.PatentsWhat REGN is filing at the patent office.